vimarsana.com

Page 6 - கோசில முயற்சிகள் கையகப்படுத்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Valo Health and Khosla Ventures Acquisition Co to Combine and Create Publicly Traded Company Focused on Transforming the Drug Discovery and Development Process

/PRNewswire/ Valo Health, LLC ("Valo"), the technology company using human-centric data and artificial intelligence (AI) powered computation to transform.

The latest SPAC deal to know about: Valo Health to combine with Khosla Ventures Acquisition

Khosla Ventures Acquisition Co II Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report

Share this article Share this article MENLO PARK, Calif., June 2, 2021 /PRNewswire/  Khosla Ventures Acquisition Co. II (the Company ) announced today that, on May 28, 2021, it received a notice ( Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market ( Nasdaq ) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the Rule ) because the Company failed to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the Form 10-Q ) with the Securities and Exchange Commission ( SEC ). The Notice has no immediate effect on the listing or trading of the Company s securities on the Nasdaq Capital Market.

Khosla Ventures Acquisition Co III Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report

Share this article Share this article MENLO PARK, Calif., June 2, 2021 /PRNewswire/  Khosla Ventures Acquisition Co. III (the Company ) announced today that, on May 28, 2021, it received a notice ( Notice ) from the Listing Qualifications Department of The Nasdaq Stock Market ( Nasdaq ) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the Rule ) because the Company failed to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the Form 10-Q ) with the Securities and Exchange Commission ( SEC ). The Notice has no immediate effect on the listing or trading of the Company s securities on the Nasdaq Capital Market.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.